EcoDrugPlus

Adenosine Deaminase

Ensembl ID : ENSLBEG00000024755
Gene Symbol: ADA
3 Cross references
216 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSLBEG00000015584
Gene Symbol: LOC109994812
3 Cross references
173 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSLBEG00000025011
Gene Symbol: LOC109981767
2 Cross references
142 Possible Orthologues:

Adenosine Receptor A3-Like

Ensembl ID : ENSLBEG00000008872
Gene Symbol: LOC109984874
2 Cross references
39 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSLBEG00000002191
Gene Symbol: ADRA1B
1 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSLBEG00000004981
Gene Symbol: ADRA1B
3 Cross references
191 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSLBEG00000027746
Gene Symbol: ADRA1D
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSLBEG00000004626
Gene Symbol: ADRA2A
1 Cross references
159 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSLBEG00000014480
Gene Symbol: ADRA2B
1 Cross references
174 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSLBEG00000026067
Gene Symbol: ADRA2C
2 Cross references
157 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSLBEG00000004330
Gene Symbol: ADRB1
3 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSLBEG00000001430
Gene Symbol: ADRB2
1 Cross references
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).